Literature DB >> 3063363

Seroepidemiology of Q fever in New Brunswick and Manitoba.

T J Marrie1.   

Abstract

A seroepidemiological survey, using an indirect immunofluorescence test, was carried out on serum samples obtained from New Brunswick and Manitoba blood donors during 1986. The antigens were Coxiella burnetii phase I and phase II from strain Nine Mile. Eighty of the 503 (15.9%) Manitoba blood donors had a phase II antibody titer of greater than or equal to 1:8, while 41 (4.2%) of the 966 New Brunswick blood donors had such antibodies. We have recently diagnosed three cases of Q fever in New Brunswick but none have been diagnosed in Manitoba. Our data suggest that Q fever may be increasing in New Brunswick and repeated seroepidemiological studies are indicated. It is likely that undetected cases of Q fever are occurring in Manitoba.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3063363     DOI: 10.1139/m88-183

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  4 in total

1.  Q fever endocarditis: a case report and review of the literature.

Authors:  Marc W Deyell; Brian Chiu; David B Ross; Nanette Alvarez
Journal:  Can J Cardiol       Date:  2006-07       Impact factor: 5.223

2.  Seroepidemiology of Coxiella burnetii infection and its frequency as a cause of community-acquired pneumonia in Canada.

Authors:  Thomas J Marrie; Emidio de Carolis
Journal:  Can J Infect Dis       Date:  2002-05

3.  Coxiella burnetii seroprevalence of shepherds and their flocks in the lower Saint-Lawrence River region of Quebec, Canada.

Authors:  Patrick Dolcé; Marie-Joële Bélanger; Krzysztof Tumanowicz; Claude P Gauthier; Philippe Jutras; Richard Massé; Claude Montpetit; Harold Bernatchez; Dorothy McColl; Harvey Artsob
Journal:  Can J Infect Dis       Date:  2003-03

4.  Goat-associated Q fever: a new disease in Newfoundland.

Authors:  T F Hatchette; R C Hudson; W F Schlech; N A Campbell; J E Hatchette; S Ratnam; D Raoult; C Donovan; T J Marrie
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.